Sravan K. Emany - 16 Nov 2023 Form 4 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)

Role
SVP, Chief Financial Officer
Signature
/s/ Brian Tessler, Attorney-in-Fact
Issuer symbol
IRWD
Transactions as of
16 Nov 2023
Transactions value $
-$62,880
Form type
4
Filing time
20 Nov 2023, 16:05:22 UTC
Previous filing
16 Nov 2023
Next filing
19 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRWD Class A Common Stock Tax liability -$62.9K -6.66K -3.53% $9.44 182K 16 Nov 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units.